Halberd Co. (OTCMKTS:HALB) Short Interest Down 96.9% in January

Halberd Co. (OTCMKTS:HALB) was the recipient of a large decrease in short interest in January. As of January 15th, there was short interest totalling 700 shares, a decrease of 96.9% from the December 31st total of 22,300 shares. Based on an average daily trading volume, of 1,645,800 shares, the days-to-cover ratio is currently 0.0 days.

Halberd Price Performance

OTCMKTS HALB traded up $0.00 during trading on Thursday, reaching $0.00. The company’s stock had a trading volume of 562,265 shares, compared to its average volume of 557,688. Halberd has a 12 month low of $0.00 and a 12 month high of $0.01.

About Halberd

Halberd Corporation, a biotech company, develops treatments for neurodegenerative diseases. It offers treatments for post traumatic stress disorder/chronic traumatic encephalopathy, Alzheimer's and Parkinson's disease, cancer, blood-borne, and cerebrospinal fluid related diseases. The company was incorporated in 2009 and is based in Jackson Center, Pennsylvania.